Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126913061 | 12691306 | 1 | I | 20160809 | 20160826 | 20160826 | EXP | PHHY2016NL109897 | SANDOZ | TROELSTRA NAM, RUTTEN AMF, DUISENBERG-VAN ESSENBERG M.. MIXED DRUG INTOXICATION WITH VALPROIC ACID, QUETIAPINE AND OXAZEPAM COMBINED WITH ALCOHOL. CRITICAL ANALYSIS OF THE TREATMENT RESULTS AFTER RAPID INTERVENTION. PHARMACEUTISCH WEEKBLAD (NETHERLANDS). 2015;150(20):271-74 | 43.00 | YR | M | Y | 0.00000 | 20160826 | OT | NL | NL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126913061 | 12691306 | 1 | PS | QUETIAPINE. | QUETIAPINE | 1 | Oral | 13 G, UNK | U | 78679 | 13 | G | |||||||
| 126913061 | 12691306 | 2 | SS | VALPROATE SODIUM. | VALPROATE SODIUM | 1 | Oral | 45 G, UNK | U | 0 | 45 | G | EXTENDED RELEASE TABLET | ||||||
| 126913061 | 12691306 | 3 | SS | OXAZEPAM. | OXAZEPAM | 1 | Oral | 1.1 G, UNK | U | 0 | 1.1 | G | |||||||
| 126913061 | 12691306 | 4 | C | LEVOCARNITINE. | LEVOCARNITINE | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 126913061 | 12691306 | 5 | C | LEVOCARNITINE. | LEVOCARNITINE | 1 | Oral | 1000 MG, TID | U | 0 | 1000 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126913061 | 12691306 | 1 | Product used for unknown indication |
| 126913061 | 12691306 | 2 | Product used for unknown indication |
| 126913061 | 12691306 | 3 | Product used for unknown indication |
| 126913061 | 12691306 | 4 | Hyperammonaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126913061 | 12691306 | OT |
| 126913061 | 12691306 | HO |
| 126913061 | 12691306 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126913061 | 12691306 | Coma | |
| 126913061 | 12691306 | Condition aggravated | |
| 126913061 | 12691306 | Haemodynamic instability | |
| 126913061 | 12691306 | Intentional overdose | |
| 126913061 | 12691306 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |